More Syntara Limited news Syntara LimitedASX: SNT PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial Oct 13, 2021 at 4:20 AM UTC · Issued by Syntara Limited As issuedPlain English Syntara Limited has released a press release. View Attachment
